Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine protease 46 pseudogene (PRSS46P) is a predicted pseudogene belonging to the serine protease family. It is thought to encode a putative or non-functional serine-type endopeptidase, with no confirmed enzymatic activity and no established biological role. PRSS46P is classified as a pseudogene due to lack of evidence for protein expression or functional enzyme, and it is not considered a therapeutic target. There are no known drugs, biomarkers, or safety concerns related to this locus[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease 46 pseudogene (PRSS46P).